(VXRT) – FDA
-
Vaxart (VXRT) Receives $9.27M BARDA Project NextGen Award for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
-
Vaxart (VXRT) Reports Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine Candidate
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to VXRT Stock Lookup